Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the cancer biopsy market size evolved in recent years?

The cancer biopsy market has expanded rapidly, set to grow from $25.08 billion in 2024 to $28.52 billion in 2025 at a CAGR of 13.7%. Key factors driving past growth include increased awareness of liquid biopsy procedures, rising demand for genetic testing in oncology, growing adoption of liquid biopsies, increased preference for minimally invasive procedures, and a higher demand for tissue biopsies.

What are the predictions for the cancer biopsy market size in the coming years?

The cancer biopsy market is expected to see rapid growth, reaching $47.2 billion by 2029, with a CAGR of 13.4%. Growth is driven by an increasing number of patients, a rising elderly population, higher breast cancer suspicion rates, and an uptick in cancer diagnosis and biopsy testing. Key trends include technological advancements, the integration of artificial intelligence and machine learning, multi-omics approaches, product innovations, and point-of-care biopsy devices.

Get your cancer biopsy market report here!

https://www.thebusinessresearchcompany.com/report/cancer-biopsy-global-market-report

What key factors are fueling the growth of the cancer biopsy market?

The rising prevalence of cancer is expected to fuel the cancer biopsy market. Cancer involves abnormal cell growth and spread, with its increasing cases linked to lifestyle changes, urbanization, pollution, tobacco and alcohol use, and healthcare access. Biopsies help diagnose and assess cancer type, stage, and progression by analyzing tissue samples. As per the National Center for Biotechnology Information, the US reported 1,958,310 new cancer cases and 609,820 deaths in 2023. Additionally, the National Library of Medicine projected global cancer cases to reach 28.4 million by 2040, marking a 47% rise from 2020. Consequently, the growing cancer prevalence is driving the cancer biopsy market.

How is the global cancer biopsy market divided into key segments?

The cancer biopsymarket covered in this report is segmented –

1) By Type: Tissue Biopsies, Liquid Biopsies, Other Types

2) By Application: Breast Cancer, Colorectal Cancer, Cervical Cancers, Lung Cancers, Prostate Cancers, Skin Cancers, Blood Cancers, Kidney Cancers, Other Applications

3) By End User: Hospitals, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Tissue Biopsies: Core Needle Biopsies, Fine Needle Aspiration (FNA) Biopsies, Incisional Biopsies, Excisional Biopsies

2) By Liquid Biopsies: Circulating Tumor Cell (CTC) Analysis, Circulating Tumor DNA (ctDNA) Testing, Plasma Biomarker Testing

3) By Other Types: Bone Biopsies, Endoscopic Biopsies, Brush Biopsies, Skin Biopsies

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19355&type=smp

Who are the key firms paving the way for growth in the cancer biopsy market?

Major companies operating in the cancer biopsy market are Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Roche Diagnostics GmbH, Hologic Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Exact Sciences Corporation, Myriad Genetics Inc., Guardant Health Inc., Veracyte Inc., GRAIL Inc., Freenome Holdings Inc., Biodesix Inc., Chronix Biomedical Inc., Biocept Inc., Personal Genome Diagnostics Inc., Agena Bioscience Inc., Oncimmune Holdings plc, Exosome Diagnostics Inc., Epigenomics AG, Genesystems Inc., Lucence Diagnostics Pte. Ltd., ANGLE plc

Which trends are expected to transform the cancer biopsy market?

Major corporations in the cancer biopsy market, such as Labcorp, are pioneering liquid biopsy methods as a way to improve and personalize cancer treatment by enabling non-invasive early detection and disease tracking. The cutting-edge liquid biopsy process uses a simple blood sample to detect and study genetic material, including circulating tumor DNA, RNA, exosomes, and additional biomarkers. Labcorp, a leading US manufacturer of cancer biopsies, released Labcorp Plasma Focus in May 2023: a liquid biopsy specializing in plasma for the identification of cancer-related biomarkers. This Plasma Focus assay scrutinizes circulating cell-free DNA from tumor cells found in the bloodstream and establishes a genomic layout of the patient’s tumor. It can pinpoint mutations in 33 genes connected to a variety of cancer types like non-small cell lung cancer, colorectal cancer, breast cancer, esophageal cancer, and melanoma.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19355

What regions are contributing significantly to the growth of the cancer biopsy market?

North America was the largest region in the cancer biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Cancer Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Pancreatic Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-drugs-global-market-report

Blood Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: